Sunday November 22 2009 | Biotechnology feed | All feeds
|
|
Amerimmune Pharmaceuticals Incorporated
Download detailed PDF Members: Amerimmune is engaged in pharmaceutical research and development with the primary purpose of developing Cytolin, a drug designed to protect the immune system, especially in patients suffering from human immunodeficiency virus (HIV). The company believes that Cytolin is an important drug for the growing number of patients who have not been receiving treatment, for those who are on multi-drug therapy, and for those who have become resistant to drugs currently used to treat the HIV/AIDS virus.
This page has been viewed 340 times since April 2007, the link to the organisation's website has been followed 99 times Recent Search Terms used to find this page: amerimmune pharmaceuticals | . This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified. BioPortfolio search results for Amerimmune Pharmaceuticals Incorporated | ||||||||||||||||||||||||||
|